The escalating prevalence of individuals becoming overweight and obese is a rapidly rising
global health problem, placing an enormous burden on health and economic systems …

Purpose Type 2 diabetes (T2D) medication adherence is poor and is impacted by individual
drug characteristics. Treatment-associated weight change can affect medication-taking …

Aim To evaluate the long‐term cost‐effectiveness of tirzepatide (5, 10 and 15 mg doses), a
novel glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 …

Introduction Diabetes is a chronic metabolic disorder that affects millions of people
worldwide. Adherence to treatment is a key determinant to proper management. This study …

Introduction Sodium glucose cotransporter-2 inhibitors (SGLT2is) are an emerging class of
drugs with wide indications. Controversial evidence exists regarding the risk of urinary tract …

Background The purpose of this study was to assess the status of glycaemic control and
associated factors among patients with type 2 diabetes mellitus patients. Methods This was …

Background: The prevalence of obesity has grown significantly worldwide. It is considered a
major cardiovascular risk factor among type II diabetes mellitus (T2DM) patients. Objectives …

In diabetic patients, controversies still exist about the validity of electrodiagnostic and nerve
ultrasound diagnosis for carpal tunnel syndrome (CTS). We analyzed 69 patients with type 2 …

BACKGROUND: Tirzepatide is a novel glucose-dependent insulinotropic polypeptide and
glucagon-like peptide-1 receptor agonist approved for type 2 diabetes (T2D) treatment …

Purpose This study aimed to determine the factors affecting the ORTO-R scores in
individuals with T2DM and to investigate their effect on diabetes self-management. Methods …